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Introduction
Extreme persistence is a defining property of long-term potenti-
ation (LTP; Abraham, 2003) and perhaps the most striking of its 
many correspondences with memory. However, although the 
ultimate form of LTP is remarkably stable, its initial expression 
is easily disrupted by any of several manipulations. The time-
dependent process whereby LTP is made resistant to disturbance 
(consolidation) is known to have at least two phases: an initial 
stage lasting 10–30 min followed by a slower, protein synthesis–
dependent step (Morris et al., 2003; Lynch et al., 2007).
Certain characteristics of LTP (rapid appearance, persis-
tence, and synapse specificity) led to the proposal that rapid 
consolidation involves modifications to the subsynaptic cyto-
skeleton (Matus et al., 1982; Lynch and Baudry, 1984). In ac-
cord with this, induction of LTP in adult hippocampus causes 
the rapid emergence of F-actin in individual dendritic spines 
(Fukazawa et al., 2003; Lin et al., 2005) that, like LTP itself, 
is transiently vulnerable to disruption (Kramar et al., 2006). 
Accordingly, actin filament assembly blockers destabilize LTP 
without affecting its initial expression (Krucker et al., 2000). 
These findings suggest that cytoskeletal events are central to 
LTP consolidation but do not address how modest patterned 
activity gives rise to dramatic changes in spine cytoarchitec-
ture. Detailed descriptions of membrane receptor to cytoskel-
eton  signaling  in  developing  neurons  have  highlighted  the 
roles of small GTPases (Kuhn et al., 2000). Yet, it is not known 
how these pathways contribute to the maintenance of adult 
dendritic spines or the production of synaptic plasticity, and 
evidence that they are engaged during LTP in adult brain has 
only recently been reported (Chen et al., 2007).
An important clue about mechanisms lies in the observa-
tion that endogenous adenosine is a potent, negative modulator 
T
he releasable factor adenosine blocks the forma-
tion of long-term potentiation (LTP). These experi-
ments used this observation to uncover the synaptic 
processes that stabilize the potentiation effect. Brief adeno-
sine  infusion  blocked  stimulation-induced  actin  poly-
merization within dendritic spines along with LTP itself in 
control rat hippocampal slices but not in those pretreated 
with the actin filament stabilizer jasplakinolide. Adeno-
sine  also  blocked  activity-driven  phosphorylation  of 
synaptic  cofilin  but  not  of  synaptic  p21-activated   
kinase (PAK). A search for the upstream origins of these 
effects showed that adenosine suppressed RhoA activity 
but only modestly affected Rac and Cdc42. A RhoA   
kinase (ROCK) inhibitor reproduced adenosine’s effects on 
cofilin phosphorylation, spine actin polymerization, and 
LTP, whereas a Rac inhibitor did not. However, inhibitors 
of Rac or PAK did prolong LTP’s vulnerability to reversal 
by latrunculin, a toxin which blocks actin filament assem-
bly. Thus, LTP induction initiates two synaptic signaling 
cascades: one (RhoA-ROCK-cofilin) leads to actin poly-
merization, whereas the other (Rac-PAK) stabilizes the 
newly formed filaments.
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and then TBS was applied. The magnitude of LTP induced by 
TBS (131.0 ± 2.6% of baseline) was slightly less in JPK-
treated slices than that in untreated controls (145.0 ± 4.4%). 
This was not likely caused by disturbances of induction events 
because acute responses to TBS were not affected by JPK 
(Fig. S2), and expression of LTP at 1–2 min after TBS ap-
peared normal (Fig. 1 C). Moreover, JPK did not reduce TBS-
induced spine F-actin (Fig. 1 D). Adenosine infusions at 30 s 
after  TBS  transiently  blocked  transmission  in  JPK-treated 
slices but, in contrast to results obtained in control slices, 
failed to reverse LTP (Fig. 1, D and E).
Adenosine blocks TBS-induced  
cofilin phosphorylation
We investigated the possibility that adenosine exerts its dis-
ruptive influence on actin polymerization and LTP consolidation 
by interfering with the constitutively active actin depolymer-
izing protein cofilin, whose inactivation via phosphorylation 
is  essential  to  cytoskeletal  reorganization  (Gungabissoon 
and Bamburg, 2003) and is associated with LTP (Chen et al., 
2007). Hippocampal slices were immunolabeled and processed 
for deconvolution microscopy and reconstruction in three di-
mensions. Discrete cofilin-immunopositive (cofilin
+) structures 
(0.2–0.6 µm diameter) were present in large numbers in proxi-
mal CA1 stratum (str.) radiatum (Fig. 2 A) in association with 
similar-sized puncta immunopositive for PSD95, which is an 
integral postsynaptic density (PSD) protein. This agrees with 
evidence that cofilin is concentrated in spines in close proximity 
to excitatory synaptic junctions (Racz and Weinberg, 2006). 
Phospho-cofilin
+ (pCofilin
+) synapses had similar sizes and lo-
cations but were much less numerous (Fig. 2 B and Video 2).
We confirmed previous work (Chen et al., 2007) that LTP 
induction is followed by increases in the number of PSDs associ-
ated with dense levels of pCofilin (Fig. 2 C). Automated quanti-
fication of spine pCofilin and PSD95 immunoreactivity (ir) from 
slices in which LTP was recorded for 5 min allowed for analysis 
of colocalization across large numbers of synapses. More than 
80% of pCofilin
+ elements were also PSD95
+ (n = 7,116 syn-
apses from eight control slices). TBS caused an approximately 
threefold increase in pCofilin
+ PSDs (control vs. TBS: 3.2 ± 
1.0/100 µm
3 vs. 11.7 ± 2.7/100 µm
3; n = 7–8; P = 0.01; Fig. 2 D) 
but had no effect on the total number of PSDs in the same slices 
(P = 0.4) or numbers of total (predominately unphosphorylated) 
cofilin
+ PSDs in different slices (n = 5; P = 0.6).
We  tested  whether  the  TBS-induced  pCofilin  effect  is 
modified by adenosine. Brief (4 min) adenosine infusions to 
control slices reduced the number of pCofilin
+ synapses in CA1 
str. radiatum by 30%, and this effect was completely blocked 
by the A1R antagonist DPCPX (Fig. 3 A). Moreover, adenosine 
applied at 30 s after TBS profoundly reduced the increase in 
pCofilin
+ synapses normally found after TBS (72 ± 15% vs. 273 ± 
39% of control for adenosine vs. vehicle; n = 11 and 14; P < 
0.0001). The potent block of activity-driven cofilin phosphory-
lation by adenosine was eliminated by DPCPX (Fig. 3 A) but 
was unaffected by 10 µM of the adenosine A2a receptor antago-
nist MSX3 (117 ± 24% of control + adenosine; P = 0.52). Be-
cause adenosine depressed basal pCofilin levels, we recalculated 
of rapid consolidation. Reversal of LTP during its vulnerable 
period by hypoxia (Arai et al., 1990) or low frequency stimula-
tion (Larson et al., 1993) is mediated by released adenosine. 
In this study, based on results obtained using adenosine as a probe, 
we report the first evidence that LTP induction sets in motion 
two independent signaling cascades, one that triggers actin poly-
merization and a second that contributes to the stabilization of 
the newly assembled filaments. The combined action of the two 
pathways is required for consolidation to reach completion. 
These findings point the way to a formal hypothesis regarding a 
fundamental feature of memory encoding and are directly rele-
vant to discussions about the causes of mental retardation.
Results
Adenosine disrupts LTP consolidation  
by blocking actin polymerization in  
dendritic spines
Effects of adenosine on LTP and cytoskeletal reorganization 
were evaluated for field CA1 in adult rat hippocampal slices. 
Local application of 0.2 mM adenosine for 4 min, beginning 
30 s after LTP induction by theta burst stimulation (TBS), 
caused a transient block of synaptic responses followed by a 
rapid recovery to the pre-LTP baseline (Fig. S1). The same 
treatment at 10 min after TBS failed to reverse LTP. Thus, 
adenosine fully reverses LTP in a time-dependent manner. We 
then labeled F-actin in situ with Alexa Fluor 568–phalloidin 
(Fig. 1 A and Video 1) to test the effects of adenosine on actin 
filament assembly in dendritic spines after LTP induction. 
Adenosine’s effects on TBS-induced spine F-actin paralleled 
its actions on LTP: local application at 30 s but not 10 min after 
TBS blocked the threefold increase in the numbers of spines 
containing dense F-actin (Fig. 1 B). 0.2 µM of the selective adeno-
sine A1  receptor  (A1R)  antagonist  DPCPX  (8-cyclopentyl-1, 
3-dipropylxanthine) eliminated the suppressive action of adeno-
sine at 30 s after TBS. These results accord with earlier find-
ings (Kramar et al., 2006) and suggest that adenosine blocks 
the rapid stabilization of LTP by suppressing activity-induced 
cytoskeletal modifications.
We  tested  the  aforementioned  conclusion  using  jas-
plakinolide (JPK), a toxin which stabilizes newly formed actin 
filaments. JPK infusion caused a 40% reduction in synaptic re-
sponses without evident effect on paired pulse facilitation (PPF), 
suggesting that the toxin’s actions are not a result of altered 
transmitter release probability (Fig. 1 C). JPK blocks AMPA 
(-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate) recep-
tor (AMPAR) internalization in dissociated neurons (Zhou   
et al., 2001), but little is known about its effects on receptor cy-
cling at adult synapses. Another study suggests that JPK’s effect 
on actin stabilization slows the movement of glutamate recep-
tors between synaptic and extrasynaptic membrane compart-
ments (Ireland and Abraham, 2009). A bidirectional effect of 
this sort could slow the constitutive replacement of AMPARs 
without necessarily disrupting structural changes produced by 
TBS-driven filament assembly.
Field excitatory postsynaptic potentials (fEPSPs) were 
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Figure 1.  Adenosine reverses LTP-associated actin polymerization via the A1R in a time-dependent manner. (A) F-actin was labeled in situ with Alexa Fluor 
568–phalloidin in the region of physiological recording in adult hippocampal slices. Photomicrographs show densely phalloidin-labeled spines (arrows; i). 
Labeled spines with clear necks (arrowheads; ii) and richly labeled mushroom spines (double arrow; iii) were often detected. (B) F-actin labeling in slices 
receiving control stimulation (con) or TBS followed by local infusion of vehicle (veh), adenosine (Ado), or adenosine in the presence of 0.2 µM DPCPX. 
The plot shows the quantification (means ± SEM) of phalloidin-labeled spines for slices receiving vehicle or adenosine at the indicated minutes after TBS   
(*, P < 0.05 vs. control; #, P < 0.05 vs. adenosine at 0.5 min after TBS). (C, top) Representative fEPSP traces at time points enumerated in the plot. Vertical 
bar, 0.5 mV; horizontal bar, 5 ms. (middle) Group fEPSP slopes for slices treated with JPK (solid horizontal line). Response amplitudes were returned to 
predrug levels by adjusting stimulus intensity (downward arrow); the gap in the x axis represents the time to stabilize the new baseline (<10 min). Slices 
receiving TBS alone (upward arrow; open circles) exhibited potentiation for >40 min. Slices receiving adenosine (gray shading) beginning 30 s after TBS 
(closed circles) returned to potentiated levels after washout. (bottom) PPF (percent amplitudes of pulse 2 vs. pulse 1) at 50 ms (gray circles) or 100 ms 
(open circles) interpulse intervals in a single case from plot immediately above. (D) In situ F-actin labeling in a slice receiving TBS in the presence of JPK. 
The arrow indicates a densely labeled spine. (E) Adenosine was applied at 0.5, 2, or 10 min after TBS. LTP is presented as mean percentage (±SEM) of 
baseline for the period from 10–20 min after vehicle or adenosine washout (*, P < 0.5 vs. vehicle/TBS alone; #, P < 0.01 vs. vehicle/0.5 min after TBS). 
(C and E) Dashed lines indicate baseline levels. Bars: (A [i], B, and D) 5 µm; (A [ii]) 3 µm; (A [iii] and D [inset]) 2 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   88
application of adenosine alone increased the number of pPAK
+ 
PSDs (444 ± 120% of control; n = 11 and 7; P = 0.009; Fig. 4 B). 
This  result  indicates  that  reductions  in  baseline  levels  of   
pCofilin by adenosine (Fig. 3) are not caused by a suppression 
of the PAK–LIM kinase–cofilin pathway.
TBS caused a sixfold increase in the number of pPAK
+ 
PSDs in control slices, and this effect was not attenuated by 
adenosine infusion beginning 30 s after TBS (Fig. 4 B). Recal-
culating the data as percent increase relative to baseline in 
adenosine-treated (no TBS) slices demonstrated a TBS-induced 
increase of 484 ± 89% in the number of pPAK
+ PSDs (Fig. 4 C). 
This value is not reliably different from the effect of TBS in un-
treated slices (636 ± 78%; P = 0.2).
The approximately fourfold increase in baseline pPAK
+ 
PSDs produced by adenosine was not accompanied by an 
equivalent change in Western blot analyses of hippocampal 
slice homogenates: pPAK band ODs were not significantly dif-
ferent for samples from treated versus untreated slices (n = 18; 
P = 0.4; Fig. 4, D and E). However, correcting values for within-
lane actin levels uncovered a modest but reliable adenosine ef-
fect (0.90 ± 0.03 vs. 1.08 ± 0.07 fraction of control; P = 0.02). 
Overall, the pattern of results suggests that adenosine receptor 
activation causes translocation of pPAK to the synaptic com-
partment or that large extrasynaptic pools mask its effects at 
synapses in overall slice measures. In all, adenosine increases 
synaptic pPAK levels under control conditions but has little if 
any effect on increases in PAK phosphorylation associated with 
LTP induction.
Selective effects of adenosine  
on Rho GTPases
PAK and cofilin phosphorylation are regulated by Rho fam-
ily small GTPases in many cell systems (Gungabissoon and 
Bamburg, 2003). Accordingly, we investigated the effects of 
the effects of TBS as the percent change from the appropriate 
(adenosine treated or untreated) control group mean (Fig. 3 B). 
By this measure, TBS increased the number of pCofilin
+ PSDs by 
173 ± 39% in untreated slices but only by 44 ± 16% in slices 
treated with adenosine (P = 0.001). The full effect of TBS was re-
stored in adenosine-treated slices by preincubation with DPCPX 
(156 ± 64% of adenosine + DPCPX–treated control slices). West-
ern blot analyses confirmed that adenosine infusion reduced basal 
pCofilin levels in control slices (vehicle vs. adenosine: 39.8 ± 4.2 
vs. 26.3 ± 3.0 × 10
3 OD units; n = 19; P = 0.01; Fig. 3 C). Similar 
results were obtained when normalized to -actin.
Trains of low frequency stimulation both release adeno-
sine (Wall and Dale, 2007) and produce a time-dependent rever-
sal of LTP (Larson et al., 1993); the latter effect is blocked by 
A1R antagonists. These observations raise the possibility that 
the aforementioned A1R effects on TBS-induced pCofilin can 
be engaged by repetitive synaptic activity. We tested this using 
a 3-min-long train of 5 Hz stimulation beginning 30 s after TBS, 
a treatment known to thoroughly disrupt LTP consolidation. 
The 5-Hz train completely blocked the increase in pCofilin
+ 
PSDs that normally occurs after TBS (TBS vs. TBS + 5 Hz: 243 ± 
33% vs. 114 ± 12%; n = 5 and 11; P < 0.001; Fig. 3 D).
Adenosine does not block TBS-induced 
phosphorylation of p21-activated  
kinase (PAK)
In many cell types, cofilin phosphorylation is regulated by par-
allel signaling streams through the Rho GTPase effectors RhoA 
kinase (ROCK) and PAK. The latter is concentrated at synapses, 
regulates dendritic spine morphology, and is phosphorylated by 
TBS (Boda et al., 2004; Chen et al., 2007). Immunostaining for 
PAK3 in field CA1 produced punctate labeling resembling that 
for total cofilin; pPAK
+ structures were much less frequent and 
closely associated with PSDs (Fig. 4 A). Unexpectedly, local 
Figure 2.  3D reconstruction analysis of immuno-
fluorescence.  (A)  Deconvolution  photomicro-
graph from proximal CA1 str. radiatum shows 
total cofilin
+ elements. (B) Images show local-
ization of pCofilin
+ (left) and PSD95
+ (middle) 
elements in the same field (the arrows indicate 
overlapping  structures).  pCofilin
+  elements 
were of similar size and shape as total cofilin
+ 
elements  (but  less  numerous).  (C)  Photomicro-
graphs  (Fluor)  and  volumetric  reconstructions 
(3D)  of  a  single  synapse  containing  pCofilin 
ir  and  PSD95  ir  displayed  in  30°  clockwise 
turns  (left  to  right).  (D)  The  plot  shows  num-
bers of immunolabeled spines (mean ± SEM) 
in the field of physiological recording for slices 
receiving control stimulation (con; open bars) 
or TBS (closed bars). Counts were made from 
3D  reconstructions.  The  plot  shows  separate 
quantification of total PSD95
+, double-labeled 
cofilin  (cofilin
+/PSD95
+),  and  double-labeled 
pCofilin (pCofilin
+/PSD95
+) elements. The latter 
comparison was replicated using the Volocity 
measurement module. PSD95
+ elements asso-
ciated with pCofilin ir represented <5% of the 
total PSD95
+ puncta in control slices. Slices   
receiving TBS showed approximately threefold 
more  pCofilin
+/PSD95
+  colabeled  elements 
versus controls (**, P < 0.01). Bars: (A and B)   
5 µm; (C) 0.5 µm.89 SEQUENTIAL STEPS IN LONG-TERM POTENTIATION • Rex et al.
activates LIM kinase and in turn phosphorylates cofilin. If so, 
ROCK inhibitors should, like adenosine, reduce both baseline 
and TBS-induced pCofilin. We tested this by infusing hippo-
campal slices with 0.1 µM of the potent and selective ROCK in-
hibitor H1152 for 30 min. H1152 reduced pCofilin levels to 41 ± 
6% of control values in Western blots (n = 17; P < 0.0001) with-
out measurable effect on basal pPAK levels (Fig. 5 C).
As expected from the aforementioned results, H1152 ap-
plied alone caused a substantial reduction in baseline numbers 
of pCofilin
+ PSDs (48 ± 29% of vehicle; n = 6 and 5; P = 0.01; 
Fig. 5 D). The ROCK inhibitor also offset the increase in   
pCofilin
+ PSDs normally seen after LTP induction. We estimated 
the magnitude of this suppression by calculating the percent in-
crease produced by TBS in the presence of the ROCK inhibitor: 
the increment with TBS (TBS: 35 ± 25%) was substantially 
smaller in the presence of H1152 than in untreated slices (97 ± 15%;   
adenosine on Rho-GTPase activity in adult hippocampus with 
pull-down assays that purify active (GTP bound) RhoA or 
Cdc42/Rac. 0.2 mM adenosine treatment for 5 min markedly 
reduced levels of GTP-bound RhoA (P = 0.009), produced a 
modest inhibition of Cdc42 activity (P = 0.016), and had no 
detectable effect on Rac activity (n ≥ 10; P = 0.07; Fig. 5,   
A and B). Adenosine did not affect total levels of the three 
GTPases. These findings constitute the first evidence that adeno-
sine differentially regulates Rho GTPases in adult hippocampus 
and suggest that its reversal of LTP and activity-driven cofilin 
phosphorylation involves suppression of RhoA. From this and 
the finding that TBS triggers both PAK and cofilin phosphory-
lation, we predicted that synaptic potentiation would activate 
both Rac and RhoA. It is difficult to apply pull-down assays in 
conventional CA1 LTP experiments because only a small frac-
tion of the synaptic population is engaged (Chen et al., 2007). 
Accordingly, we used a broadly acting, chemically induced 
form of potentiation that bears several resemblances to LTP 
(Roth-Alpermann et al., 2006); as predicted, this was accom-
panied by a significant activation of RhoA and Rac (n = 5–8;   
P < 0.05) as well as pPAK and pCofilin (Fig. S3).
The aforementioned results suggest that adenosine blocks 
cofilin phosphorylation via the RhoA effector ROCK, which 
Figure  3.  Adenosine  blocks  phosphorylation  of  the  F-actin–severing 
protein cofilin. Hippocampal slices receiving TBS or control stimulation to 
the Schaffer collaterals were processed for double pCofilin (pCof) and 
PSD95 immunofluorescence. 0.2 mM adenosine (Ado) or vehicle (veh) 
was locally applied for 4 min beginning 30 s after TBS. (A) The plot shows 
mean numbers (±SEM) of pCofilin/PSD95 double-labeled puncta in the 
zone of physiological recording (*, P < 0.05; **, P < 0.01 vs. vehicle;   
#, P < 0.05; ##, P < 0.01 vs. adenosine alone). (B) Results from A ex-
pressed  as  difference  between  treatment  and  TBS  +  treatment  effects 
(TBS; mean ± SEM; **, P < 0.01 vs. vehicle; #, P < 0.05 vs. adenosine).   
(C)  Western  blots  from  tissue  treated  with  adenosine  or  vehicle  for   
5 min; plot of group mean (±SEM) band ODs shows that adenosine de-
creased pCofilin levels (*, P < 0.05). (D) Low frequency stimulation (LFS) 
blocked TBS-induced increases in numbers of pCofilin
+ PSDs (mean ± SEM;   
*, P < 0.05 vs. control; #, P < 0.05 vs. TBS).
Figure  4.  Activity-induced  PAK  phosphorylation  is  not  blocked  by   
adenosine. (A) Deconvolution images show total PAK3 ir (left) and the   
colocalization of pPAK1/2/3 and PSD95 (right panels) in proximal CA1 
str. radiatum. The arrows indicate a double-labeled element. (B) Quantifica-
tion (mean ± SEM) of pPAK
+ PSDs shows that adenosine (Ado) significantly 
increased the numbers of pPAK
+ PSDs (n = 7–11; *, P < 0.05 vs. con-
trol). TBS followed by adenosine 30 s later increased pPAK
+ PSDs above 
values in adenosine alone slices (n = 11; ***, P < 0.001 vs. control;   
##, P < 0.01 vs. adenosine). (C) Results from B presented as the difference 
between TBS + treatment and treatment alone group values (TBS; mean ±   
SEM). (D) Western blots from slices treated with adenosine or vehicle (veh) 
for 5 min (same slices as in Fig. 3 C). (E) Plots show raw band ODs 
(left) or the same measure normalized to -actin (right; means ± SEM;   
*, P = 0.02). The latter measure exposed an adenosine-induced increase 
in levels of pPAK. Bars: (A [left]) 10 µm; (A [right]) 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   90
labeled spines (P = 0.6). These results indicate that TBS inacti-
vates cofilin and thereby promotes actin filament assembly by 
stimulating adenosine-sensitive RhoA-ROCK signaling.
An important prediction from the aforementioned argument 
is that ROCK inhibition will disrupt LTP consolidation. Studies 
P = 0.04; Fig. 5 D). H1152 also blocked the TBS-induced in-
crease in spines with dense F-actin content (TBS vs. TBS + 
H1152: 2.2 ± 0.1 vs. 0.9 ± 0.3 phalloidin-labeled spines/ 
100 µm
3; n = 5–6; P = 0.001; Fig. 5 E). As with adenosine, the 
ROCK inhibitor did not alter baseline numbers of phalloidin-
Figure 5.  RhoA signaling is necessary for stable expression of LTP. (A) Western blots from vehicle (veh)- or adenosine (Ado)-treated slices probed with 
antisera for total RhoA, Cdc42, or Rac1 (left) or (in the same samples) processed by pull-down assay (middle) using GST-Rhotekin (for RhoA)– or GST-PAK 
(for Cdc42 and Rac1)–binding domains. (B) Group mean (±SEM) band OD measures from pull-downs (Active) or total protein measures for the indicated 
GTPases are expressed as adenosine treatment/control (*, P < 0.05; **, P < 0.01 vs. vehicle). (C) Western blot and plots of band densities show pPAK 
and pCofilin levels in slices treated with 0.1 µM of the ROCK inhibitor H1152 for 30 min or vehicle; H1152 selectively suppressed pCofilin ir (mean ± 
SEM; ***, P < 0.001 vs. vehicle). (D, left) Slices were treated with H1152 for 30 min before TBS and harvested 7 min after TBS for immunofluorescence; 
numbers of pCofilin
+ PSDs in the zone of physiological recording are shown (*, P < 0.05 vs. vehicle/control; #, P < 0.05 vs. H1152 alone). (right) Object 
counts, presented as the mean (±SEM) difference between TBS + treatment and treatment alone groups (TBS; *, P < 0.05), show that H1152 blocks 
the TBS effect. (E) Images show in situ F-actin labeling in slices receiving TBS alone or TBS + ROCK inhibitor. Group mean (±SEM) numbers of phalloidin-
labeled spines/100 µm
3 for TBS- and control-stimulated (con) slices in the absence (ACSF) or presence of H1152 are shown (*, P < 0.05 vs. control;   
#, P < 0.05 vs. ACSF-TBS). (F) Slices were treated with H1152 (solid horizontal line) for 50 min before TBS (arrow). H1152-treated slices (closed circles) 
showed normal initial potentiation compared with vehicle controls, but LTP failed to stabilize. (top) Baseline (left) and 60-min post-TBS (right) fEPSP traces. 
Vertical bar, 1 mV; horizontal bar, 10 ms. (B and F) Dashed lines indicate baseline levels. Bar, 5 µm.91 SEQUENTIAL STEPS IN LONG-TERM POTENTIATION • Rex et al.
that is sensitive to adenosine and another (Cdc42/Rac-PAK-?) 
that is not. After establishing that RhoA signaling is linked to 
TBS-induced actin polymerization, we investigated the effects 
of disrupting Rho GTPase–PAK signaling on the expression 
and stabilization of LTP. Given the absence of widely tested 
Cdc42 inhibitors, we used the highly selective small molecule 
inhibitor NSC23766 to block Rac GTPase activity (Gao et al., 
2004). This compound interferes with binding of Rac-specific 
guanine exchange factors without disrupting Cdc42 or RhoA 
GTP/GDP exchange.
Treatment with 0.1 mM of the Rac inhibitor for 1 h reduced 
levels of GTP-Rac by >30% (n = 4–5; P = 0.04; Fig. 6 A) without 
detectably changing PAK or cofilin phosphorylation (Fig. S5). 
NSC23766 has similarly little effect on basal levels of pPAK in 
Schwann cells, suggesting that Rac may not constitutively acti-
vate this effector (Thaxton et al., 2007). The inhibitor also did not 
reduce basal synaptic pPAK in slices (Fig. 6 B). However, it did 
completely block TBS-induced increases in numbers of pPAK
+ 
PSDs (TBS vs. TBS + NSC23766: 204 ± 25% vs. 103 ± 16%;   
n = 6; P = 0.002). Despite this, the Rac inhibitor did not disrupt 
TBS-induced increases in spines containing dense F-actin   
using Y-type inhibitors have described mixed results (O’Kane   
et al., 2004; Wang et al., 2005); the more selective H1152 (Sasaki 
et al., 2002) has only been tested in the dentate gyrus, where it 
blocked LTP (Huang et al., 2007). We measured LTP in slices in-
fused with concentrations of H1152 (0.1 µM) sufficient to block 
cofilin phosphorylation. The inhibitor had no discernible effects 
on input–output relationships or PPF of synaptic responses   
(Fig. S4) and did not alter baseline responses (Fig. 5 F). LTP in-
duced in the presence of H1152 failed to stabilize: the initially 
potentiated responses returned to near baseline levels within 60 min 
(vehicle vs. H1152: 151 ± 9% vs. 111 ± 7% of baseline; n = 4 
and 7; P = 0.005). In particular, the ROCK inhibitor appeared to 
exert its influence on consolidation because it had no effect on the 
size of burst responses used to induce LTP (Fig. S4) and did not 
change initial potentiation (vehicle vs. H1152: 284 ± 9% vs. 248 ± 
22% for 0–1 min after TBS; P = 0.2).
Rac-PAK signaling is required for  
LTP stabilization
The aforementioned results lead to the hypothesis that TBS sets in 
motion two parallel signaling cascades, one (RhoA-ROCK-cofilin) 
Figure 6.  Inhibition of activity-driven PAK phosphorylation does not block LTP or activity-induced spine F-actin. (A) Hippocampal slices were treated with 
0.1 mM of the Rac inhibitor NSC23766 or vehicle (veh) for 1 h and processed for Rac pull-down assay. Representative blot and group mean (±SEM) 
values show that NSC23766 reduced active Rac1 levels by >30% (*, P < 0.01 vs. vehicle). (B) Slices were treated for 30 min with the Rac inhibitor before 
TBS and harvested 7 min after TBS for immunofluorescence. NSC23766 did not affect baseline levels of pPAK
+ PSDs when applied alone but did block 
the effects of TBS on this measure (**, P < 0.01 vs. control). The right plot shows mean (±SEM) values of the same measures expressed as the difference 
between TBS + treatment and treatment alone groups (***, P < 0.001 vs. vehicle). (C) Images show in situ F-actin labeling in slices receiving TBS alone or 
TBS + NSC23766. The plot shows group mean (±SEM) numbers of labeled spines/100 µm
3 (*, P < 0.01 vs. ACSF; #, P = 0.01 vs. NSC23766 alone). 
con, control. (D) The Rac inhibitor was applied to slices for 30 min before TBS (arrow) and remained throughout recording; no effects on LTP were observed 
in comparison to vehicle control slices. (E) LTP induced by TBS (arrow) in the presence of the Rac inhibitor did not show reversal after 6-min local adenosine 
treatment (gray shading) beginning 10 min after TBS. (D and E) Dashed lines indicate baseline levels. Bar, 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   92
If NSC23766 acts on Rac-PAK signaling to prolong the 
period during which Lat A reverses LTP, a selective inhibitor of 
PAK should reproduce its effects. To test this point, we used a 
small molecule, IPA-3, that directly and noncompetitively in-
hibits Group I PAK activity (i.e., PAK1–3; Deacon et al., 2008). 
2 µM of the PAK inhibitor applied to slices for 1 h, at a concen-
tration reported to block PAK1 activity without affecting 200 
related kinases, blocked 50% of PAK phosphorylation at Thr423 
(n = 6; P = 0.02 vs. control; Fig. 7 C). This catalytic domain site 
concludes a serial autophosphorylation chain triggered by   
GTPase binding (i.e., Cdc42 or Rac) and therefore represents 
one of the final modifications required for PAK to carry out its 
kinase activity (Chong et al., 2001). However, it did not block 
phosphorylation at the initial Ser141 autophosphorylation site 
within the regulatory domain (n = 6; P > 0.05 vs. control; Fig. 7 C). 
This result is expected from the inhibitory mechanism of   
IPA-3, which is believed to prevent PAK activity by stabilizing 
the kinase in a semi-open, catalytically inactive conformation   
(Deacon et al., 2008).
Slices incubated for 1 h with 2 µM IPA-3 showed no overt 
disturbances to baseline synaptic responses (Fig. 7 D). LTP ap-
peared normal in the majority (78%) of inhibitor-treated cases, 
and we used these to challenge its stability. 0.2 µM Lat A infu-
sions, initiated at 30 min after TBS and continued throughout 
recording, caused the potentiated responses to gradually decay 
back to their preinduction baseline values (the percentage of 
LTP at 2.5 h after induction was 105 ± 8%; n = 7; P = 0.6   
vs. baseline; Fig. 7 D). Collectively, the aforementioned findings 
point to the presence of TBS-driven Rac-PAK signaling that, in 
spines, is insensitive to adenosine but critical for the stabiliza-
tion of LTP-related cytoskeletal changes.
Discussion
Multiple lines of evidence indicate that adenosine, released dur-
ing LTP induction, acts as a negative modulator of processes that 
stabilize recently generated synaptic potentiation. We found that 
extracellular adenosine, acting through A1Rs, blocks TBS-
induced actin polymerization when applied shortly after stimula-
tion. That actin polymerization is the central event underlying 
LTP’s initial window of vulnerability is supported in this study 
by the demonstration that TBS-induced spine actin polymeriza-
tion and synaptic potentiation exhibit similar patterns of vulner-
ability to Lat A, which prevents filament assembly. This argument 
predicts that, absent its potent influence on actin polymerization, 
adenosine would have no effect on LTP stabilization. We con-
firmed this by showing that the actin filament stabilizer JPK al-
lowed LTP consolidation to go to completion despite the presence 
of adenosine. This accords with recent evidence that JPK can 
block reversal of late-phase LTP (Messaoudi et al., 2007).
The question then became one of how extracellular adeno-
sine interferes with F-actin assembly in dendritic spines. We 
confirmed our previous finding (Chen et al., 2007) that LTP in-
duction is followed by rapid phosphorylation of the actin-severing 
protein cofilin. Phosphorylation inactivates cofilin by prevent-
ing its binding to actin filaments (Gungabissoon and Bamburg, 
2003) and thus promotes actin polymerization and filament 
(TBS vs. TBS + NSC23766: 3.3 ± 0.6 vs. 3.1 ± 0.4 spines/100 µm
3; 
n = 9; P = 0.47; Fig. 6 C).
We then tested whether Rac-PAK signaling contributes to 
LTP. Infusion of the inhibitor for 30 min before TBS did not af-
fect baseline physiology or initial expression and subsequent 
maintenance of LTP (P > 0.6 vs. vehicle; Fig. 6 D). We then 
asked whether NSC23766 affects processes that render LTP re-
sistant to disruption. Adenosine infusion beginning 10 min after 
TBS, a time point at which it does not affect LTP (Fig. 1 A), was 
also without effect on potentiation in Rac inhibitor–treated slices 
(Fig. 6 E). These findings indicate that blocking TBS-induced 
phosphorylation of synaptic PAK does not prolong the period 
over which LTP is vulnerable to adenosine.
We next tested for a contribution of Rac/PAK on the stabi-
lization of TBS-induced spine F-actin. Newly assembled actin 
filaments in various cell systems commonly remain in a dy-
namic state (“treadmilling”) until stabilized by various special-
ized protein systems. Latrunculin A (Lat A) disrupts treadmilling 
by preventing the addition of actin monomers to growing fila-
ments, and this produces sizeable alterations to AMPAR cur-
rents at sufficient concentrations (>5 µM; Kim and Lisman, 
1999; Zhou et al., 2001). Therefore, we used a dose (0.2 µM) 
that blocks LTP consolidation when applied before or shortly 
after TBS without evident effect on basal synaptic physiology 
(Krucker et al., 2000). We confirmed this using 4-min-long   
local infusions of Lat A to slices: infusions initiated 30 s or 2 min 
but not 10 or 30 min after TBS caused potentiated responses to 
return to near baseline within 90 min (Fig. 7 A). Accordingly, 
Lat A applied at the early (30 s or 2 min) but not late (10 or 30 min) 
time points also disrupted the spine F-actin increases typically 
observed after TBS. This finding provides a first demonstration 
that the F-actin assembled within spines after TBS shifts from   
a dynamic to a stable state over a period of several minutes and 
strongly suggests that this transition is the event underlying the 
consolidation of LTP.
LTP’s resistance to Lat A at 10 or more minutes after 
TBS was not overcome by longer infusions: 80-min Lat A ap-
plications initiated 10 min after LTP induction were ineffective 
at reversing potentiation (Fig. 7 B), suggesting that, under nor-
mal conditions, TBS-induced filaments are fully stabilized by 
this point. In contrast, Lat A infusions beginning 10 min after 
TBS caused potentiated responses to gradually decay back to 
their  pre-TBS  baselines  in  slices  pretreated  with  0.1  mM 
NSC23766 for 30 min. The difference in Lat A’s effects on 
percent LTP at the conclusion of recording in untreated (51 ± 
4%) and Rac inhibitor–treated (10 ± 7%) slices was highly sig-
nificant (n = 8; P = 0.001). Notably, Lat A caused no changes 
to unpotentiated responses (control pathway) recorded from 
the same slices infused with the Rac inhibitor. In parallel ex-
periments, we pretreated slices with 0.1 mM NSC23766 for   
30 min or vehicle, induced LTP, infused 0.2 µM Lat A 10 min 
later, and then labeled F-actin in situ with phalloidin. Lat A 
significantly reduced the numbers of F-actin–dense spines in 
NSC23766-treated but not vehicle-treated slices (Fig. S5), con-
firming that Rac inhibition extends the post-LTP induction pe-
riod over which TBS-induced spine F-actin requires continuous 
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lation. These results demonstrate that A1R activation either blocks 
phosphorylation or greatly accelerates dephosphorylation of 
synaptic cofilin and thereby presumably increases the net activ-
ity of the protein. Therefore, they describe a mechanism through 
which adenosine prevents the actin polymerization needed for 
LTP stabilization.
loading (Niwa et al., 2002; Thirone et al., 2009). Adenosine, ap-
plied after the initial expression of LTP and acting via A1Rs, 
completely suppressed the three- to fourfold increase in pCofilin
+ 
synapses produced by TBS. Low frequency stimulation, which 
blocks actin polymerization and LTP in an A1R-dependent   
fashion, also interfered with TBS-induced cofilin phosphory-
Figure 7.  Inhibition of Rac-PAK signaling extends the period over which actin filament assembly is required for LTP. Stimulation was applied to Schaffer 
collateral afferents to hippocampal field CA1b. (A) Slices labeled for F-actin after 4-min local infusion of 0.2 µM Lat A. (left) Images show that Lat A blocked 
increases in phalloidin-labeled spines when applied 30 s but not 10 min after TBS. (middle) The plot shows F-actin–labeled spine counts (mean ± SEM) from 
slices treated with vehicle (veh) at 30 s after TBS or with Lat A initiated at the time points indicated (*, P < 0.05 vs. control). (right) The plot shows mean LTP 
magnitude (percent fEPSP slope measured 80–90 min after TBS vs. baseline) from experiments in which slices were treated locally with Lat A or vehicle for 
4 min beginning at the time points indicated (**, P < 0.01 vs. respective control pathways). Measures for untreated, unstimulated (control [con]) slices are 
also shown. The dashed line indicates baseline level. (B) Prolonged Lat A bath infusion (open horizontal line), timed to hit slices at 10 min after TBS (arrow), 
did not disrupt LTP when applied alone (with vehicle) but blocked the stable maintenance of LTP in the presence of the Rac inhibitor NSC23766 (closed 
horizontal bar). A second control pathway (triangles) not receiving TBS was unaffected by drug manipulations. (top) Representative fEPSP traces collected 
at time points indicated in the plot. (C) Western blots from slices incubated with 2 µM of the Group I PAK–specific inhibitor IPA-3 for 1 h and probed for 
pPAK
S141 or pPAK
T423. -Actin bands shown were generated from the stripped PAK
T423 blot. Plots show group mean (±SEM) band densities as a fraction of 
vehicle controls (*, P < 0.05 vs. vehicle). (D) Slices incubated for 50 min with 2 µM IPA-3 (closed horizontal bar) before TBS (arrow; TBS pathway shown 
as closed circles) exhibited stable LTP of typical magnitude (dashed line), but Lat A washed in at 30 min after TBS caused potentiation to decay to baseline 
levels within 2 h. The unstimulated control pathway (open triangles) was unaffected by drug manipulations. (top) Representative fEPSP traces from the time 
points indicated. (B and D) Vertical bar, 1 mV; horizontal bar, 10 ms. Bar, 5 µm.JCB • VOLUME 186 • NUMBER 1 • 2009   94
TBS-induced increases in pCofilin
+ synapses and caused LTP to 
gradually decay back to baseline. In contrast, inhibition of Rac 
or PAK activity failed to produce the type of decremental LTP 
found with any of several treatments that block actin polymeriza-
tion. This is consistent with the finding that suppression of PAK 
activity by overexpressing its inhibitory subunit does not detect-
ably affect the decay rate of hippocampal LTP (Hayashi et al., 
2004). In all, the results indicate that TBS sets in motion two sig-
naling cascades, one of which leads to the actin filament assem-
bly needed for LTP consolidation and another which has different 
functions (Fig. 8).
The present experiments provide evidence that activa-
tion of Rac-PAK signaling in synapses is part of the system 
whereby cytoskeletal changes needed to consolidate LTP are 
stabilized. Results in this study show that disruption of activity-
induced actin polymerization by Lat A is time dependent 
relative to TBS, suggesting that the newly formed actin poly-
mers cease treadmilling, an action typically involving filament 
capping, cross-linking, or nucleating proteins (Cooper and 
Sept, 2008). This idea is supported by evidence that PAK regu-
lates proteins that support the filament branch nucleator Arp2/3, 
including cortactin and WAVE (Takahashi and Suzuki, 2009; 
Webb et al., 2006). In line with this, this study showed that in-
hibition of Rac or PAK prolonged the period over which LTP 
remains vulnerable to disruption by disassembly of dynamic 
filaments by latrunculin.
Adenosine’s actions on LTP-related actin signaling were 
surprisingly selective; after TBS, adenosine infusions did not 
affect the marked increases in the number of pPAK
+ synapses 
induced with LTP. LIM kinase is directly activated by PAK, 
and this action mediates PAK’s regulation of cofilin (Bokoch, 
2003). We previously proposed that TBS-induced cofilin phos-
phorylation in spines is regulated in this manner (Chen et al., 
2007), but the present results argue against this idea and sug-
gest instead that LTP induction initiates parallel signaling path-
ways, one of which goes through ROCK to cofilin and a second 
that involves PAK.
Rho GTPases, which translate transmembrane signaling 
to the actin cytoskeleton, are a logical starting point for analyses 
of upstream mediators of adenosine’s differential actions on 
LTP consolidation events. In this study, we show that an NMDA 
(N-methyl-d-aspartate) receptor–dependent, chemically induced 
synaptic potentiation robustly activates RhoA and Rac, effects 
which are in accord with evidence that Rho GTPases are acti-
vated by Ca
2+ influx through NMDA receptors (Semenova et al., 
2007). Rho GTPase activity may also be driven by other factors 
(e.g., neurotrophins) released by TBS and known to produce ef-
fects through these enzymes (Gehler et al., 2004). Adenosine 
caused a profound inhibition of RhoA activity, a modest sup-
pression of Cdc42, and no change in Rac activity. This pattern 
fits well with the effects of adenosine on PAK and cofilin be-
cause PAK is an effector for Cdc42 and Rac, whereas RhoA, 
acting through ROCK, drives cofilin phosphorylation (Bokoch, 
2003). The results obtained in adult brain slices in this study 
may be a reflection of a developmentally conserved system be-
cause growth cone collapse and expansion are regulated by 
opposing Cdc42/Rac and RhoA activities (Huber et al., 2003). 
Moreover, this pathway distinction appears to persist at least 
through the early development of dendritic spines (Tashiro et al., 
2000; Carlisle et al., 2008) and matches recent evidence that 
adenosine’s actions on pituicyte morphology require RhoA but 
not Rac activity (Rosso et al., 2007). In the latter system, evi-
dence suggests that signaling through the A1R inhibits RhoA 
via G protein regulation of a GTPase activating protein.
That adenosine increases baseline PAK phosphorylation 
while modestly depressing PAK’s upstream activator Cdc42 is 
not entirely unexpected. There are multiple routes (e.g., Rac and 
sphingosine) for PAK activation, and one or more of these may 
be downstream from the A1R. But the key result with regard to 
LTP is that TBS-driven synaptic PAK phosphorylation is un-
affected by adenosine. Thus, the transient activation of Rac-PAK 
signaling during LTP induction is likely to progress without   
being significantly influenced by adenosine.
The diverse adenosine results described in the previous 
paragraphs help to clarify the signaling pathways used by pat-
terned afferent activity to reorganize the spine cytoskeleton   
and stabilize an otherwise transient potentiation of synaptic re-
sponses. As discussed, TBS-driven cofilin phosphorylation, 
likely an essential step for triggering actin polymerization within 
spines, appears to involve an adenosine-sensitive, RhoA-initiated 
signaling cascade rather than Cdc42/Rac-PAK–LIM kinase 
signaling. In accord with this, a ROCK inhibitor, at concen-
trations that had no effect on pPAK, thoroughly suppressed 
Figure 8.  Schematic of processes regulating cytoskeletal dynamics during 
LTP stabilization. The proposed model shows signaling cascades that regu-
late distinct stages of dendritic spine actin reorganization. Activity-driven 
RhoA to cofilin signaling, leading to F-actin assembly, is rapid (2 min) 
and A1R sensitive. Evidence from other systems suggests that A1R inhibits 
RhoA through a GTPase-activating protein (GAP). Parallel activation of PAK 
via Rac is adenosine insensitive and influences later (>10 min) LTP consoli-
dation events. The dashed PAK to LIM kinase (LIMK) arrow denotes signal-
ing, shown in neurons and other cell systems, that does not appear to be 
involved in synaptic potentiation or its concomitant actin polymerization. 
Rather, results in this study suggest that LTP-related PAK signaling regulates 
proteins involved in higher order organization of the spine cytoskeleton. 
The independence of the described signaling pathways and their func-
tional roles in LTP suggest that activity-induced cytoskeletal reorganization 
has distinct and sequential stages involving RhoA and then Rac signaling. 
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were prepared in DMSO; MSX3 (3-[3-hydroxypropyl]-8-[3-methoxystyryl]-
7-methyl-1-propargylxanthine;  Sigma-Aldrich)  and  NSC23766  (Tocris) 
were prepared in double-distilled H2O. Compounds were diluted in ACSF 
(<0.1% DMSO) and applied to the bath via perfusion line or local infusion 
(0.2 ml/min) using a glass micropipette (tip diameter 25 µm; concentra-
tions estimated after dilution in bath) controlled by a motorized injection 
pump (model 341B; Sage Instruments; Rex et al., 2007).
In situ labeling of F-actin
Alexa Fluor 568–phalloidin (6 µM in pipette; Invitrogen) was applied to 
slices (four 3-min intervals) beginning 15 min before TBS or drug infusion. 
Slices were collected 7–15 min after TBS or as stated and processed for 
microscopy as described in Deconvolution microscopy and quantification 
of synaptic structures. Labeling was quantified using in-house software (Rex 
et al., 2007). For tests using local Lat A application, phalloidin was ap-
plied (four 3-min intervals) beginning 20 min after the removal of the drug. 
Phalloidin  applied  after  TBS  produces  comparable  results  with  pre-TBS   
applications (Rex et al., 2007). Unless otherwise stated, values in the fig-
ures and text are presented per 550 µm
2 from collapsed 20-µm z stacks. 
Values presented per unit volume (100 µm
3) represent images processed 
and analyzed as described in Deconvolution microscopy and quantifica-
tion of synaptic structures.
Immunocytochemistry
Fixed slices were sectioned (20 µm), slide mounted, and processed using 
a primary antisera cocktail of mouse anti-PSD95 (Thermo Fisher Scientific) 
with rabbit antisera to pPAK1/2/3
S141 (Invitrogen), pCofilin
S3 (Abcam), 
PAK3 (Millipore), or cofilin (Cytoskeleton, Inc.) and secondary antisera, in-
cluding Alexa Fluor 488 anti–mouse and Alexa Fluor 594 anti–rabbit (Invit-
rogen; Chen et al., 2007).
Deconvolution microscopy and quantification of synaptic structures
Z-series (0.2-µm steps) images were acquired at 63× (Plan-Apochromat 
NA 1.4) using a microscope (DM6000; Leica) and a charge-coupled de-
vice camera (Orca ER; Hamamatsu Photonics). Images were collected 
from two to four sections situated 20–80 µm below the atmosphere inter-
face of each slice. Iterative deconvolution (99% confidence) was per-
formed  by  Volocity  4.1  (PerkinElmer).  Point  spread  functions  were 
calculated from multispectral microspheres (0.5-µm diameter; Invitrogen) 
in fixed tissue sections.
Labeled synaptic structures were measured and counted from a 
136 × 105 × 3–µm (x, y, z) sampling zone in proximal str. radiatum be-
tween the two stimulating electrodes. Sample objects (i.e., pCofilin
+ ele-
ments) were small relative to image size (5.8 ± 0.3% cumulative object 
pixel area for PSD95
+ elements; n = 15), regularly shaped, and diffusely 
scattered throughout the image, thus allowing for automatic image cor-
rection,  intensity  normalization,  and  object  identification.  Acquisition-
based  nonuniformities  were  corrected  point  by  point  using  white 
(illumination only) and dark (shutter closed) background images. The 
slow shading component was obtained by low-pass filter and removed 
from image z stacks. Intensity normalization to a target background level 
(15% of maximum) was performed on image subsections (10 × 10 ×   
1 µm) to standardize object quantification across sections and batches of 
tissue (Rout et al., 2004). Image manipulations were performed using 
Matlab 7 (Mathworks).
Object  identification  was  performed  using  a  3D  variant  of  an   
established protocol (Lin et al., 2005; Chen et al., 2007). Pixel values   
(8 bit) were iteratively binarized using a fixed interval intensity threshold 
series (4% intervals from 15–75% of maximum) followed by erosion and 
dilation  filtering.  This  protocol  reliably  detected  boundaries  of  both 
faintly and densely labeled punctate structures. Object area (>0.04 and 
<1.2 µm
3) and eccentricity criteria were applied to eliminate artifact.   
Phosphoprotein
+ and PSD95
+ objects were considered to reside in the   
same synapse if any overlap between their respective boundaries was 
detected. The isolated TBS component (TBS) was calculated from double-
labeled object counts (O) from TBS and control (CON) slices as follows: 
TBS O O O TBS CON CON ∆ = − ( )/ . Image acquisition and analysis were 
conducted blind to treatment.
Western blot analysis
Samples (two to three pooled slices) were homogenized in radioimmuno-
precipitation assay buffer containing 10 mM Tris, pH 7.2, 158 mM NaCl, 
1 mM EDTA, 0.1% SDS, 1% Na-deoxycholate, 1% Triton X-100, 1× com-
plete protease inhibitor cocktail (Roche), and phosphatase inhibitor cock-
tails 1–2 (Sigma-Aldrich; Rex et al., 2007). Samples were normalized 
by Bio-Rad protein assay and processed for Western blot analysis (12% 
The evidence that Rac-PAK signaling is critical to stabili-
zation as opposed to assembly events occurring 10–15 min after 
TBS does not preclude a role in later protein synthesis–dependent 
stages of LTP. Recent work suggests that latrunculin-sensitive 
changes in the spine cytoskeleton link synaptic activity to local 
protein synthesis (Smart et al., 2003; Sacktor, 2008), whereas 
knockout mouse experiments indicate that loss of PAK3 or WAVE 
selectively impairs late-phase, presumably protein synthesis de-
pendent, LTP (Meng et al., 2005; Soderling et al., 2007). Thus, 
it is not unlikely that Rac-PAK signaling helps shape transla-
tional responses to LTP induction.
It is of interest that portions of the membrane receptor to cyto-
skeleton signaling machinery identified in the present work have 
been implicated in disorders of memory and cognition. Mutations 
disrupting gene products that regulate or transduce Rho GTPase 
activity are associated with mental retardation (van Galen and   
Ramakers, 2005). Moreover, abnormalities in Rac-PAK signaling 
may contribute to the fragile X mental retardation syndrome (FXS) 
phenotype (Linseman and Loucks, 2008). Actin remodeling is dis-
turbed in a mouse model of FXS, and suppression of PAK activity 
with a dominant-negative transgene reduces FXS-related structural 
and functional abnormalities (Hayashi et al., 2007). Our results 
suggest that perturbations to Rac-PAK signaling will be accompa-
nied by relatively discrete changes to synaptic operations in adult 
brain and, in particular, should leave baseline transmission as well 
as the induction and early expression of LTP intact. Conversely, 
mental retardation–related mutations that involve proteins acting on 
RhoA (e.g., oligophrenin 1) would be expected to have more potent 
effects on synaptic plasticity.
Materials and methods
All procedures were conducted in accordance with guidelines of the 
National Institutes of Health and the Institutional Animal Care and Use 
Committee of the University of California.
Electrophysiology
350-µm transverse hippocampal slices were prepared from 4–8-wk-old male 
Sprague Dawley (Harlan) rats in ice cold artificial cerebral spinal fluid (ACSF) 
containing 124 mM NaCl, 3 mM KCl, 1.25 mM KH2PO4, 5 mM MgSO4,   
26 mM NaHCO3, 3.4 mM CaCl2, and 10 mM dextrose using a vibroslicer 
(VT1000; Leica). Slices were maintained in an interface recording chamber 
(at 32°C with 95% O2/5% CO2) with constant 60–70 ml/min ACSF perfusion 
(Rex et al., 2007). Field electrophysiology was performed using two bipolar 
stimulating electrodes (65-µm twisted nichrome wire) placed in mid-proximal 
str. radiatum of CA1a and CA1c to stimulate independent populations of syn-
apses recorded with a glass electrode (2 M NaCl) in CA1b (Chen et al., 
2007). Baseline responses were set at 40–50% of maximum spike-free fEPSPs. 
For JPK experiments, responses were set at 30% of the maximum. LTP was in-
duced by TBS (10 bursts of four pulses at 100 Hz with 200-ms interburst inter-
vals). For some preparations, one pathway remained unstimulated as a control 
pathway. fEPSP slope values in figures and text are measured as 10–90% fall 
and are normalized to the 10 min before drug infusion or TBS. Input/output 
(stimulation duration vs. fEPSP amplitude) was performed as 10–20-µs dura-
tion steps and repeated three times for each step. PPF was measured as the 
percent fEPSP amplitude change between successive pulses tested at 10–
100-ms interpulse intervals (repeated three times for each interval). For contin-
uous assessment of PPF, single pulse test stimulation was replaced by paired 
test pulses (fEPSP slopes measured from responses to the first pulse only). Slices 
used for microscopic analysis were harvested 7 min after TBS and fixed in 4% 
PFA in 0.1 M of sodium phosphate buffer. n values represent slices/group.
Drugs
Adenosine (EMD), DPCPX (Tocris), JPK (Invitrogen), H1152 (EMD), Lat A 
(Invitrogen), and 1,1-disulfanediyldinaphthalen (IPA-3; Sigma-Aldrich) JCB • VOLUME 186 • NUMBER 1 • 2009   96
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SDS-PAGE) using rabbit antisera to pCofilin
S3, pPAK1/2/3
S141 (see Immuno-
cytochemistry), or pPAK1/2/3
T423 (Cell Signaling Technology) and the ECL 
Plus detection system (GE Healthcare). Blots were reblotted (Millipore) and 
probed for -tubulin and -actin (Sigma-Aldrich). Immunoreactive bands 
were measured using ImageJ (National Institutes of Health). n values repre-
sent the numbers of samples tested.
Pull-down assays for activated Rho GTPases
Samples (6–10 pooled slices) were homogenized in Mg
2+ lysis buffer (Milli-
pore) with complete protease inhibitor cocktail, normalized, and then as-
sayed using RhoA or Cdc42/Rac pull-down kits (Millipore). Samples were 
incubated with Rac/Cdc42 (PAK1 PAK-binding domain) or RhoA (Rhotekin-
binding domain) and rocked for 2 h. Rhotekin binds strongly to RhoA and 
RhoC (absent in brain) but weakly to RhoB (Reid et al., 1996); thus, only RhoA 
is detected with antisera to RhoA. Agarose beads were collected by centrifu-
gation (for 10 s at 14,000 g and 4°C), washed, resuspended in Laemmli buf-
fer, and boiled for 5 min. Western blot analysis (12% SDS-PAGE) used mouse 
anti-RhoA (Santa Cruz Biotechnology, Inc.), mouse anti-Rac (Millipore), or rab-
bit anti-Cdc42 (Millipore). GTP and GDP loading controls were incubated with 
100 µM GTP-S or 1 mM GDP for 30 min at 30°C.
Statistics
All  values  in  figures,  figure  captions,  and  text  represent  group  means   
± SEM. Unless stated otherwise, group differences for single pulse stimula-
tion (final 10 min of recording), input/output, PPF, and continuous PPF 
were assessed by repeated measures analysis of variance. For quantifica-
tion of immunopositive elements and Western blots, statistical significance 
(P ≤ 0.05) was determined by analysis of variance followed by Tukey’s 
post hoc test or two-tailed Student’s t test using SPSS 15.0 (SSPS, Inc.). 
Curve fitting and statistical tests were performed using Matlab 7.
Online supplemental material
Fig. S1 shows the effect of short adenosine infusions on LTP and pre-
synaptic release probability when applied 2 or 10 min after TBS. Fig. S2 
shows that JPK does not alter presynaptic release probability or acute re-
sponses to TBS. Fig. S3 describes the effects of chemically induced synap-
tic potentiation on Rho GTPases and PAK and cofilin activity. Fig. S4 shows 
that the ROCK inhibitor H1152 does not alter basic synaptic physiology 
or acute responses to potentiating stimuli. Fig. S5 shows the effects of 
the Rac inhibitor NSC23766 on spine F-actin in slices challenged with 
Lat A at 10 min after TBS. Video 1 shows representative labeling (3D 
reconstruction)  for  F-actin  by  phalloidin  applied  in  situ  from  slices  re-
ceiving  TBS  or  control  stimulation.  Video  2  shows  an  example  field 
(CA1 str. radiatum) reconstructed in three dimensions from pCofilin and 
PSD95 ir. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200901084/DC1.
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